Showing results (601-610 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|February 16, 2018
Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitorsTanaya Vaidya, Jeff Kamta, Maher Chaar, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteersB Wang, T M Ludden, E N Cheung, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Impact of pharmacokinetic-pharmacodynamic model linearization on the accuracy of population information matrix and optimal designY Merlé, M TodJournal of Pharmacokinetics and Pharmacodynamics|January 5, 2002
Ways to fit a PK model with some data below the quantification limitS L BealJournal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamideA D Huitema, R A Mathôt, M M Tibben, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Efficient screening of covariates in population models using Wald's approximation to the likelihood ratio testK G Kowalski, M M HutmacherJournal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in childrenF Mentré, C Dubruc, J P ThénotJournal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
General pharmacokinetic model for drugs exhibiting target-mediated drug dispositionD E Mager, W J JuskoJournal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effectT Minematsu, H Ohtani, Y Yamada, et al.Pageof 107